02 Dec Eight ventures pitch for investment
On 27 November, eight innovative start-ups from the Oxford AHSN Accelerator, delivered by BioCity presented their progress and their pitches for future investment to a panel of experts from Oxford AHSN, BioCity and industry.
Their pitches were the culmination of the second Oxford AHSN Accelerator programme, delivered by BioCity. The panel will now decide which of the ventures offers the strongest solution to the proven NHS and UK life science’s needs.
The wide-ranging innovations relate to early cancer diagnosis, remote monitoring and diagnostics, digital health and service delivery. Over the eight-week programme the cohort tested their concepts with expert mentors from industry, investment, and healthcare worlds. Due to restrictions imposed by the Covid-19 pandemic, this year’s programme ran entirely virtually with sessions and online support provided by the BioCity platform.
Dr Paul Durrands, Chief Operating Officer of the Oxford AHSN, said: “In a challenging year for all innovators, it is testament to the commitment and hard work of all the companies that they’ve successfully completed this second Oxford AHSN Accelerator Programme. The progress that each company made over the programme, in an entirely virtual environment, was amazing to see.”
UPDATE: The winner of the programme has been announced, huge congratulations to MetaGuideX. MetaGuideX are developing new cancer diagnostics, giving novel insights to cancer metastasis.
We will be opening the next Accelerator programme in early 2021.